Clinical Trials Arena - News and Views Updated Daily

Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Advertise with us

Eisai and Biogen report positive topline Phase II data of BAN2401

Japan-based Eisai and Biogen have reported positive topline results from the Phase II Study 201...
Read More...

Eisai and Biogen report positive topline Phase II data of BAN2401

Supporting mental health in a business environment

Download a free 10 page preview of our Mergers & Acquisitions in TMT – Thematic Research 2019 Report